TD Waterhouse Canada’s Karyopharm Therapeutics KPTI Stock Holding History

TD Waterhouse Canada’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.5K	Buy	5,707 +2,504	+78%	+$21.7K	﹤0.01%	1400
2026 Q1	$18.6K	Hold	3,203	–	–	﹤0.01%	1599
2025 Q4	$23.5K	Hold	3,203	–	–	﹤0.01%	1363
2025 Q3	$19.9K	Hold	3,203	–	–	﹤0.01%	1384
2025 Q2	$14K	Hold	3,203	–	–	﹤0.01%	1381
2025 Q1	$11.3K	Hold	3,203	–	–	﹤0.01%	1376
2024 Q4	$32.2K	Buy	+3,203	New	+$38.7K	﹤0.01%	1181
2024 Q1	–	Sell	-137	Closed	-$1.7K	–	1865
2023 Q4	$1.7K	Hold	137	–	–	﹤0.01%	1514
2023 Q3	$2.49K	Buy	137 +66	+93%	+$1.48K	﹤0.01%	1473
2023 Q2	$1.9K	Hold	71	–	–	﹤0.01%	1543
2023 Q1	$4.22K	Hold	71	–	–	﹤0.01%	1405
2022 Q4	$3.44K	Hold	71	–	–	﹤0.01%	1418
2022 Q3	$6.07K	Hold	71	–	–	﹤0.01%	1321
2022 Q2	$5K	Hold	71	–	–	﹤0.01%	1392
2022 Q1	$8.54K	Hold	71	–	–	﹤0.01%	1363
2021 Q4	$7.8K	Buy	+71	New	+$7.08K	﹤0.01%	1383

Other funds holding KPTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

TD Waterhouse Canada's KPTI Position: Q2 2026 in Review

TD Waterhouse Canada increased its Karyopharm Therapeutics (KPTI) stake by 78% in Q2 2026, buying an estimated $21.7K and bringing the position to 5,707 shares worth $54.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

TD Waterhouse Canada first reported a position in KPTI in Q4 2021 and has held it in 16 quarters since. 21 funds tracked by Wall St. Rank hold KPTI as of Q2 2026.

TD Waterhouse Canada held 5,707 shares of Karyopharm Therapeutics worth $54.5K as of Q2 2026.
TD Waterhouse Canada bought 2,504 Karyopharm Therapeutics shares in Q2 2026, an estimated $21.7K.
Karyopharm Therapeutics made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1400 holding.
TD Waterhouse Canada first reported a position in Karyopharm Therapeutics in Q4 2021 and has held it in 16 quarters since.
21 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.